Literature DB >> 12622458

Investigation of the pharmaceutical and pharmacological equivalence of different Hawthorn extracts.

W Vierling1, N Brand, F Gaedcke, K H Sensch, E Schneider, M Scholz.   

Abstract

Seven Hawthorn extracts were tested in isolated guinea pig aorta rings. The effect on noradrenaline- (10 microM) induced contraction was investigated. The extracts were prepared using ethanol (40 to 70% v/v), methanol (40 to 70% v/v), and water as the extraction solvents. The aqueous-alcoholic extracts displayed similar spectra of constituents. They were characterised by similar procyanidin, flavonoid, total vitexin and total phenols content and by similar TLC fingerprint chromatograms. The aqueous extract, however, showed a different fingerprint and a noticeably lower concentration of procyanidins, flavonoids and total phenols but a similar total vitexin content. All 7 extracts had a relaxant effect on the aorta precontracted by noradrenaline and led to relaxations to 44 until 29% of the initial values. The EC50 values of the aqueous-alcoholic extracts varied between 4.16 and 9.8 mg/l. The aqueous extract produced a similarly strong maximal relaxation as the other extracts, but the EC50, at 22.39 mg/l, was markedly higher. The results show that Hawthorn extracts with comparable quality profiles were obtained by using aqueous-alcoholic extraction solvents (40 to 70% ethanol or methanol). The extracts exerted comparable pharmacological effects. When using water as the extraction solvent, both, the spectrum of constituents and the pharmacological effect, deviated remarkably. It is thus possible to obtain bioequivalent extracts with comparable effect profiles by using 40 to 70% ethanol or methanol as the extraction solvent.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12622458     DOI: 10.1078/094471103321648601

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  7 in total

1.  Hawthorn (Crataegus monogyna Jacq.) extract exhibits atropine-sensitive activity in a cultured cardiomyocyte assay.

Authors:  Satin Salehi; Shannon R Long; Philip J Proteau; Theresa M Filtz
Journal:  J Nat Med       Date:  2008-08-12       Impact factor: 2.343

2.  Cardioprotective properties of Crataegus oxycantha extract against ischemia-reperfusion injury.

Authors:  J K Swaminathan; M Khan; I K Mohan; K Selvendiran; S Niranjali Devaraj; B K Rivera; P Kuppusamy
Journal:  Phytomedicine       Date:  2010-02-18       Impact factor: 5.340

3.  Hawthorn (Crataegus spp.) in the treatment of cardiovascular disease.

Authors:  Mary C Tassell; Rosari Kingston; Deirdre Gilroy; Mary Lehane; Ambrose Furey
Journal:  Pharmacogn Rev       Date:  2010-01

4.  Effect of hawthorn standardized extract on flow mediated dilation in prehypertensive and mildly hypertensive adults: a randomized, controlled cross-over trial.

Authors:  Gary N Asher; Anthony J Viera; Mark A Weaver; Rosalie Dominik; Melissa Caughey; Alan L Hinderliter
Journal:  BMC Complement Altern Med       Date:  2012-03-29       Impact factor: 3.659

Review 5.  Polyphenolic profile and biological activity of Chinese hawthorn (Crataegus pinnatifida BUNGE) fruits.

Authors:  Tunde Jurikova; Jiri Sochor; Otakar Rop; Jiri Mlcek; Stefan Balla; Ladislav Szekeres; Vojtech Adam; Rene Kizek
Journal:  Molecules       Date:  2012-12-06       Impact factor: 4.411

6.  Optimizing Water-Based Extraction of Bioactive Principles of Hawthorn: From Experimental Laboratory Research to Homemade Preparations.

Authors:  Phu Cao Ngoc; Laurent Leclercq; Jean-Christophe Rossi; Isabelle Desvignes; Jasmine Hertzog; Anne-Sylvie Fabiano-Tixier; Farid Chemat; Philippe Schmitt-Kopplin; Hervé Cottet
Journal:  Molecules       Date:  2019-12-03       Impact factor: 4.411

7.  Is Our Natural Food Our Homeostasis? Array of a Thousand Effect-Directed Profiles of 68 Herbs and Spices.

Authors:  Tamara Schreiner; Dorena Sauter; Maren Friz; Julia Heil; Gertrud Elisabeth Morlock
Journal:  Front Pharmacol       Date:  2021-12-09       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.